SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-037617
Filing Date
2022-11-14
Accepted
2022-11-14 16:01:09
Documents
14
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcon-8k_20221114.htm   iXBRL 8-K 43154
2 EX-99.1 tcon-ex991_15.htm EX-99.1 100505
3 GRAPHIC gkfe1jrmterv000001.jpg GRAPHIC 12142
  Complete submission text file 0001564590-22-037617.txt   300949

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tcon-20221114.xsd EX-101.SCH 5605
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20221114_lab.xml EX-101.LAB 19324
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20221114_pre.xml EX-101.PRE 11498
8 EXTRACTED XBRL INSTANCE DOCUMENT tcon-8k_20221114_htm.xml XML 3563
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 221384835
SIC: 2836 Biological Products, (No Diagnostic Substances)